Cite
MLA Citation
Theresa Barnes et al.. “106 Switching stable rheumatology patients from an originator biologic to a biosimilar: resource cost in the UK.” Rheumatology, vol. 57, n.d., p. . http://access.bl.uk/ark:/81055/vdc_100095493608.0x00001c